• Home
  • Why a Reverse Mortgage Lender Just Hired a Geriatrician
Why a Reverse Mortgage Lender Just Hired a Geriatrician
By Dana Jerlo profile image Dana Jerlo
3 min read

Why a Reverse Mortgage Lender Just Hired a Geriatrician

Dr. Samir Sinha, Director of Geriatrics at Mount Sinai and the University Health Network in Toronto, just took a consulting role at Canada's largest reverse mortgage lender. The position didn't exist until HomeEquity Bank created it for him this month.

That tells you something about where the industry thinks it's going.

The reverse mortgage market in Canada cleared $7.5 billion in outstanding debt in 2025, according to OSFI. Growth has been consistent, driven mostly by demographics: one in five Canadians is now 65 or older. The aging curve is not theoretical anymore. It's showing up in portfolio composition at every major lender.

But HomeEquity Bank's move is less about volume growth and more about repositioning the product itself. Reverse mortgages have spent decades fighting their reputation as a last-resort option for broke seniors. Bringing in a globally recognized geriatrician signals an attempt to reframe home equity not as emergency liquidity but as strategic infrastructure for aging in place.

The equity-to-care pipeline

Roughly 90% of Canadian seniors say they want to stay in their own homes as long as possible, according to National Institute on Ageing research. The preference is consistent across income levels. What changes is the ability to pay for it.

Aging in place at 72 is one thing. Aging in place at 84 with mobility issues, cognitive decline, and the need for part-time nursing is another. The cost structure flips. Private home care in most provinces runs $5,000 to $8,000 per month for high-intensity support. A wheelchair ramp, stair lift, and bathroom retrofit can hit $40,000. The family home that was paid off and cost-neutral becomes the most expensive part of the retirement plan.

Seniors hold over $1 trillion in residential real estate in Canada. Most of it is locked. The question HomeEquity Bank is positioning itself to answer is: what if that equity became the dedicated funding mechanism for the care that keeps you out of institutional long-term care?

Sinha has spent years criticizing Canada's LTC system. His involvement gives the bank a credibility layer it couldn't buy with marketing. It also shifts the framing from "borrow against your house" to "fund your independence."

The interest rate problem nobody mentions

A reverse mortgage compounds. No monthly payments means the interest accrues against the principal, and over 15 or 20 years, the math gets steep. The loan balance can double or triple depending on the rate environment and how long the borrower lives in the home.

That's fine if the goal is to avoid moving and the heirs understand the estate will be smaller. It's less fine if the senior later needs to sell and move to a higher level of care, only to find the reverse mortgage has consumed most of the home's value and there's not enough left to fund the transition.

The hired geriatrician model works only if the medical advice stays independent of the commercial interest. Sinha's credibility rests on his record as a systems critic. If his role becomes a channel for loan volume rather than a check on when the product makes sense and when it doesn't, the partnership loses its value.

What this means for the industry

Other lenders will watch this closely. If HomeEquity Bank can integrate a medical voice into the sales conversation without triggering ethical blowback, expect competitors to hire their own gerontologists and occupational therapists within 18 months.

The underlying shift is real. Financial planning and health planning for retirees are converging because the biggest unpredictable expense in retirement isn't travel or hobbies. It's care. Home equity is the only reserve most middle-class Canadians have left when income and savings run out.

Whether that reserve gets accessed through a reverse mortgage, a HELOC, or an outright sale is a secondary question. The primary one is whether the financial industry can advise on it without pretending the medical reality doesn't exist. HomeEquity Bank just made a $7.5 billion bet that it can.